- Price
Supplier Type
- Manufacturer
- Trader
- custom synthesis
- Reagent
- contract manufacturer
Supplier Region
- Gujarat(24)
- Maharashtra(16)
- Mumbai(35)
- Hyderabad(8)
- Bangalore(1)
- Pune(2)
- Delhi(9)
- Ahmedabad(6)
- Punjab(3)
- New Delhi(2)
- Nagpur(2)
- Tamil Nadu(1)
- Vadodara(3)
- Telangana(2)
- Beijing(1)
- Haryana(2)
- Kolkata(1)
- Uttar Pradesh(1)
Purity
- more than 90%
- Greater than 99%
- 99.9%
- 99.55%
- ≥ 99.5%
- 99.5%
- 99% Minimum
- > 99%
- 99%
- >99%
- 99
- 98.70%
- 98.0%
- 98%
- >98%
- 98 %
- 97-99%
- 97.84%
- 97%
- 96.40%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- >95%
- 95%
- 93.0 % Min
- >92%
- 90-95%
- 90% min
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 75%
- 68.0 % Min
- 65%
- 60%
- 5
- 100%
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 5g
- 10g
- 25g
- 25gm
- 50gm
- 50g
- 100gm
- 100g
- 200gm
- 250gm
- 500gm
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 100Kg
- 1MT
- 1and gm
- 50 gms
- 100 gms
- 500gms
- 250250 mg.
-
BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER)
103129-58-4
-
Bendamustine Impurity D
191939-34-1
-
R 72111
152542-00-2
-
(S)-2-Aminobutyramide hydrochloride
7682-20-4
-
(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride
1217655-87-2
-
Naproxen sodium
26159-34-2
-
Naproxen
22204-53-1
-
6-HYDROXY-2,4,5-TRIAMINOPYRIMIDINE SULFATE
39267-74-8
-
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5
-
Cyclopropylacetylene
6746-94-7
BENAZEPRIL RELATED COMPOUND G 103129-58-4
Naproxen sodium salt 26159-34-2
Naproxen sodium salt 26159-34-2
6-Hydroxy-2,4,5-triaminopyrimidine sulfate 39267-74-8
Orange G 1936-15-8
Irinotecan Impurity G 947687-01-6
Efavirenz USP Related Compound C 391860-73-4
Poly(DL-Lactide)-co-Glycolide, DLG857E, M.W:76,000 – 115,000 da, I.V: 0.71 – 1.00 dL/g 26780-50-7
InStock